The use of melatonin and co-treatment with autologous or allogeneic cells as a model for control of malignant beta-cell leukemia.
Nir
I
I
Hebrew University, Faculty of Medicine, Jerusalem, Israel.
Weiss
L
L
Slavin
S
S
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D015448:Leukemia, B-Cell / Q000628:therapy*; D008550:Melatonin / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014407:Tumor Cells, Cultured; D014916:Whole-Body Irradiation
D000975:Antioxidants; D008550:Melatonin